These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35999612)

  • 1. αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.
    Gu Y; Du Y; Jiang L; Tang X; Li A; Zhao Y; Lang Y; Liu X; Liu J
    J Nanobiotechnology; 2022 Aug; 20(1):384. PubMed ID: 35999612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.
    Jiang L; Gu Y; Du Y; Tang X; Wu X; Liu J
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42411-42428. PubMed ID: 34464081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α
    Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
    J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
    Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
    Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
    He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
    Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.
    Li L; He D; Guo Q; Zhang Z; Ru D; Wang L; Gong K; Liu F; Duan Y; Li H
    J Nanobiotechnology; 2022 Jan; 20(1):50. PubMed ID: 35078498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma.
    He D; Xu X; Li L; Chen C; Gong K; Guo Q; Liu F; Wang Y; Duan Y; Li H
    J Biomed Nanotechnol; 2021 Mar; 17(3):426-438. PubMed ID: 33875077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.
    Zou Y; Wei Y; Sun Y; Bao J; Yao F; Li Z; Meng F; Hu C; Storm G; Zhong Z
    Theranostics; 2019; 9(26):8061-8072. PubMed ID: 31754381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
    Wang Y; Liu T; Li H
    J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin.
    Kumar DN; Chaudhuri A; Dehari D; Gamper AM; Kumar D; Agrawal AK
    Mol Pharm; 2024 Jun; 21(6):3061-3076. PubMed ID: 38757678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
    Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.
    Cai XJ; Fei WD; Xu YY; Xu H; Yang GY; Cao JW; Ni JJ; Wang Z
    Drug Deliv Transl Res; 2020 Feb; 10(1):93-107. PubMed ID: 31418132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
    Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
    Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas.
    Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S
    Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
    Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
    Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.